1800 202 8726
Prostate biopsy results

What Does Gleason 6 Mean? — Is It Really Cancer?

A Gleason 6 result is the most favourable finding a prostate biopsy can produce. Understanding what it does — and does not — mean is the difference between a decision made clearly and one made in fear.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Lowest possible score — Modern prostate pathology does not report anything below Gleason 6. It is Grade Group 1, the most favourable category.
  • Cells look nearly normal — Gleason 6 cells show only mild differences from healthy prostate tissue and very little tendency to spread.
  • Over-treatment is a documented risk — Many men with Gleason 6 are treated when monitoring alone would have been safe, according to NCCN and AUA guidance.
  • Active surveillance is an established option — For suitable patients, careful monitoring without immediate treatment is the recommended approach, not a compromise.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Gleason 6, also called Grade Group 1, is the lowest score a prostate biopsy can report. It means the cells look only slightly different from normal prostate tissue. NCCN and AUA guidelines recommend active surveillance — careful monitoring without immediate treatment — for many men with Gleason 6 and no other concerning features.

Is Gleason 6 the same as cancer?

Gleason 6 is assigned when the two most common cell patterns seen in your biopsy are both rated 3. This is why it is written as 3+3=6. The cells look only mildly different from normal prostate tissue.

Whether to call Gleason 6 cancer at all is genuinely debated among pathologists and urologists. Some professional societies have proposed renaming Grade Group 1 to reflect that the cells show very little tendency to spread beyond the prostate. What is agreed is that it is the most favourable result a prostate biopsy can produce.

Your urologist will weigh the Gleason score alongside your PSA level, how many biopsy cores were involved, how much of each core was affected, and your age and general health. No treatment decision rests on the Gleason score alone.

What to bring to your next appointment

  • Your full pathology report, not just the summary page
  • Your PSA history — the last two or three readings, not only the most recent
  • A note of any other findings mentioned, such as perineural invasion or percentage of core involved
  • Questions about whether active surveillance is an option for you specifically
  • A list of any herbal, ayurvedic, or other supplements you are taking
  • Whether any close male relatives have been diagnosed with prostate cancer

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Words on your biopsy report, explained

Gleason score
Two numbers added together, each rated 1 to 5. The first is the most common pattern of cells seen; the second is the next most common. A score of 6 means both are rated 3 — the least abnormal pattern.
Grade Group
A five-level system that replaced older Gleason descriptions to make reporting clearer. Gleason 6 (3+3) is Grade Group 1, the lowest and most favourable group.
Positive cores
How many of the biopsy samples taken contained abnormal cells. Fewer positive cores generally supports a lower-risk picture.
Percentage of core involved
What fraction of each biopsy sample was affected. A low percentage in few cores supports a lower-risk assessment.
Perineural invasion
Whether cells are seen near nerve fibres within the prostate. It is noted on the report and your urologist will discuss its significance — it is not part of the Gleason score.
Adenocarcinoma of the prostate
The standard pathology term on most prostate biopsy reports. It names the cell type; the Gleason score and Grade Group describe how abnormal those cells look.

Questions families ask after a Gleason 6 result

Does Gleason 6 mean we should operate immediately?

Not necessarily. NCCN and AUA guidelines describe active surveillance as the preferred approach for many patients with Grade Group 1 disease. Surgery and radiation carry documented risks — incontinence and erectile dysfunction among them — that need weighing against a cancer that may not cause harm in a patient's lifetime. Ask your urologist specifically why they are recommending treatment, and whether a second opinion at a centre with an active surveillance programme would be worthwhile.

What is active surveillance, exactly?

Planned monitoring on a schedule your urologist sets — usually regular PSA tests, repeat biopsies at intervals, and sometimes MRI scans. If any test shows the cancer is changing, treatment is discussed at that point. The aim is to avoid side effects for as long as the cancer remains low-risk. It is structured and evidence-based, not simply waiting and hoping.

Can the Gleason score change over time?

A repeat biopsy may return a different score — either because the cancer has progressed, or because the first sample came from a different part of the gland. A change in grade is one of the signals that prompts a discussion about treatment. This is why active surveillance includes regular re-testing: to detect any change early enough to act on it.

What does '2 out of 12 cores positive' mean?

It refers to how many biopsy samples contained abnormal cells. Fewer positive cores generally supports a lower-risk picture. Your urologist considers this number alongside the Gleason grade, the percentage of each core affected, and your PSA. None of these figures tells the complete story on its own — the combination is what your urologist is assessing.

Is a second opinion on the pathology worth getting?

Yes, and it is widely considered good practice for prostate biopsy results. Gleason grading requires expert judgement, and pathologists at high-volume centres see many more cases. A second opinion on the slides themselves — not just a review of the written report — can confirm the grade or occasionally change it. Your urologist can advise on where to send the slides. Asking does not imply a problem with your original pathologist.

Does family history change what Gleason 6 means?

Family history does not change how your grade is interpreted, but it may affect how closely your urologist monitors you. Tell your team about any close male relatives — father, brothers — diagnosed with prostate cancer. Your result reflects the biology of your specific tumour, not a family pattern. Your urologist will factor it in when setting a monitoring or treatment plan.

Explore 114 more Waiting For and Understanding Your Report topics

HUB — Cytology and Prostate Scoring Systems Explained

HUB — Understanding Your Biopsy Report

HUB — Waiting for Biopsy Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What is the difference between Gleason 6 and Gleason 7?

Gleason 7 means at least one pattern in your biopsy is rated grade 4, which looks more abnormal and has a greater tendency to grow beyond the prostate. Gleason 6 contains only grade 3 patterns. Most urologists manage these two scores differently. If your report says 7, ask whether it is 3+4 or 4+3 — those two carry different implications even though the total is the same.

If Gleason 6 is low risk, why was I offered surgery or radiation?

Practice varies between doctors and centres. Some urologists treat Grade Group 1 because of other features on the report — many positive cores, a high PSA, or a patient's preference for definitive treatment. Ask your urologist specifically why active surveillance was not offered for you, and consider a second opinion at a centre with an established active surveillance programme.

Can I just monitor it myself without going back for tests?

No. Active surveillance is structured monitoring carried out with your urologist on a defined schedule. It is safe precisely because it is designed to detect any change early enough to act on it. If you have concerns about how often tests are needed or what they involve, raise those directly with your urologist — but do not simply stop attending.

Will I need a repeat biopsy?

Most active surveillance programmes include repeat biopsies on a schedule — typically within the first one to two years and then at intervals your urologist sets. MRI is increasingly used to guide decisions about when and where a repeat biopsy is needed. In a proportion of men on active surveillance, the grade does not change over many years, and treatment is never needed.

Does diet or lifestyle affect Gleason 6?

No diet, supplement, or lifestyle change has been shown to reliably eliminate Gleason 6 or replace structured monitoring. Staying physically active and maintaining a healthy weight have general health benefits. Be cautious about supplements marketed specifically for prostate cancer — some interact with medications. Tell your team about everything you are taking, including herbal or ayurvedic preparations.

What questions should I ask at my next appointment?

Ask four things: what exactly the pathology report shows, including all findings not just the Gleason score; whether active surveillance is an option given your specific result; if treatment is recommended, what the likely side effects are and what the alternatives are; and whether a second opinion on the pathology or the management plan would be appropriate. Bring someone with you if you can — these conversations are hard to recall clearly afterwards.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation